That's just speculations and a sure way to lose money. Vvus doesn't have catalysts in near future, the weight loss drug got delayed so the shares are paying the price.
Besides, keep in mind that ARNA approval/rejection could also weight on the vvus shares, so smart money are getting out of vvus and waiting to reenter closer to mid-July catalyst.
News 
Market Data 
Discover 
AI
